{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T11:14:54Z","timestamp":1723288494284},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s15010-013-0489-9","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T14:12:56Z","timestamp":1370355176000},"page":"903-907","source":"Crossref","is-referenced-by-count":6,"title":["Toxicity and adherence to treatment for latent tuberculosis infection in patients with hematologic malignancies"],"prefix":"10.1007","volume":"41","author":[{"given":"E. M.","family":"S\u00e1nchez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gamallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Blanco-Moure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Viejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Amador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Anibarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"key":"489_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1179\/146532808X302125","volume":"28","author":"DC Stefan","year":"2008","unstructured":"Stefan DC, Kruis AL, Schaaf HS, Wessels G. Tuberculosis in oncology patients. Ann Trop Paediatr. 2008;28:111\u20136.","journal-title":"Ann Trop Paediatr"},{"key":"489_CR2","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/1097-0142(197403)33:3<850::AID-CNCR2820330334>3.0.CO;2-H","volume":"33","author":"MH Kaplan","year":"1974","unstructured":"Kaplan MH, Armstrong D, Rosen P. Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer. 1974;33:850\u20138.","journal-title":"Cancer"},{"key":"489_CR3","first-page":"125","volume":"15","author":"CY Wu","year":"2011","unstructured":"Wu CY, Hu HY, Pu CY, et al. Aerodigestive tract, lung and haematological cancers are risk factors for tuberculosis: an 8-year population-based study. Int J Tuberc Lung Dis. 2011;15:125\u201330.","journal-title":"Int J Tuberc Lung Dis"},{"key":"489_CR4","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1086\/503917","volume":"42","author":"M Kamboj","year":"2006","unstructured":"Kamboj M, Sepkowitz KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis. 2006;42:1592\u20135.","journal-title":"Clin Infect Dis"},{"key":"489_CR5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1471-2334-11-324","volume":"11","author":"CY Chen","year":"2011","unstructured":"Chen CY, Sheng WH, Cheng A, et al. Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies. BMC Infect Dis. 2011;11:324.","journal-title":"BMC Infect Dis"},{"key":"489_CR6","first-page":"1110","volume":"90","author":"FA Silva","year":"2005","unstructured":"Silva FA, Matos JO, de Q Mello FC, Nucci M. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica. 2005;90:1110\u20135.","journal-title":"Haematologica"},{"key":"489_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/qjmed\/hcq068","volume":"103","author":"ME Falagas","year":"2010","unstructured":"Falagas ME, Kouranos VD, Athanassa Z, Kopterides P. Tuberculosis and malignancy. QJM. 2010;103:461\u201387.","journal-title":"QJM"},{"key":"489_CR8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1469-0691.2004.00954.x","volume":"10","author":"GR Rosa De La","year":"2004","unstructured":"De La Rosa GR, Jacobson KL, Rolston KV, Raad II, Kontoyiannis DP, Safdar A. Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990\u20132000. Clin Microbiol Infect. 2004;10:749\u201352.","journal-title":"Clin Microbiol Infect"},{"key":"489_CR9","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMcp021045","volume":"347","author":"RM Jasmer","year":"2002","unstructured":"Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med. 2002;347:1860\u20136.","journal-title":"N Engl J Med"},{"key":"489_CR10","doi-asserted-by":"crossref","first-page":"297.e1","DOI":"10.1016\/j.eimc.2010.02.006","volume":"28","author":"J Gonz\u00e1lez-Mart\u00edn","year":"2010","unstructured":"Gonz\u00e1lez-Mart\u00edn J, Garc\u00eda-Garc\u00eda JM, Anibarro L, et al. Consensus document on the diagnosis, treatment and prevention of tuberculosis. Enferm Infecc Microbiol Clin. 2010;28:297.e1\u201320.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"489_CR11","doi-asserted-by":"crossref","unstructured":"Carvalho AC, Schumacher RF, Bigoni S, et al. Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology\u2013oncology ward after exposure to a patient with pulmonary tuberculosis. Infection. 2013 (Epub ahead of print). doi: 10.1007\/s15010-013-0450-y .","DOI":"10.1007\/s15010-013-0450-y"},{"key":"489_CR12","first-page":"1","volume":"49","author":"[No authors listed]","year":"2000","unstructured":"[No authors listed]. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep. 2000;49:1\u201351.","journal-title":"MMWR Recomm Rep"},{"key":"489_CR13","unstructured":"Treatment for latent tuberculosis infection. Core curriculum on tuberculosis: what the clinician should know. Centers for Disease Control and Prevention. National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of Tuberculosis Elimination. 2011. p. 109\u201337. http:\/\/www.cdc.gov\/tb\/education\/corecurr\/pdf\/chapter5.pdf"},{"key":"489_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1183\/09031936.00203811","volume":"39","author":"GB Migliori","year":"2012","unstructured":"Migliori GB, Zellweger JP, Abubakar I, et al. European union standards for tuberculosis care. Eur Respir J. 2012;39:807\u201319.","journal-title":"Eur Respir J"},{"key":"489_CR15","first-page":"701","volume":"14","author":"L Anibarro","year":"2010","unstructured":"Anibarro L, Casas S, Paz-Esquete J, et al. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain. Int J Tuberc Lung Dis. 2010;14:701\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"489_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s15010-008-8087-y","volume":"37","author":"PJ Cardona","year":"2009","unstructured":"Cardona PJ. A dynamic reinfection hypothesis of latent tuberculosis infection. Infection. 2009;37:80\u20136.","journal-title":"Infection"},{"key":"489_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00005382-199701000-00006","volume":"12","author":"HI Libshitz","year":"1997","unstructured":"Libshitz HI, Pannu HK, Elting LS, Cooksley CD. Tuberculosis in cancer patients: an update. J Thorac Imaging. 1997;12:41\u20136.","journal-title":"J Thorac Imaging"},{"key":"489_CR18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-011-1407-7","volume":"31","author":"CY Chen","year":"2012","unstructured":"Chen CY, Sheng WH, Lai CC, et al. Mycobacterial infections in adult patients with hematological malignancy. Eur J Clin Microbiol Infect Dis. 2012;31:1059\u201366.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"489_CR19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","volume":"341","author":"PA Pizzo","year":"1999","unstructured":"Pizzo PA. Fever in immunocompromised patients. N Engl J Med. 1999;341:893\u2013900.","journal-title":"N Engl J Med"},{"key":"489_CR20","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365:2155\u201366.","journal-title":"N Engl J Med"},{"key":"489_CR21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1378\/chest.07-2024","volume":"133","author":"A Kwara","year":"2008","unstructured":"Kwara A, Herold JS, Machan JT, Carter EJ. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Chest. 2008;133:862\u20138.","journal-title":"Chest"},{"key":"489_CR22","first-page":"1374","volume":"14","author":"H Kunst","year":"2010","unstructured":"Kunst H, Khan KS. Age-related risk of hepatotoxicity in the treatment of latent tuberculosis infection: a systematic review. Int J Tuberc Lung Dis. 2010;14:1374\u201381.","journal-title":"Int J Tuberc Lung Dis"},{"key":"489_CR23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0213-005X(11)70015-5","volume":"29","author":"M Sant\u00edn Cerezales","year":"2011","unstructured":"Sant\u00edn Cerezales M, Ben\u00edtez JD. Diagnosis of tuberculosis infection using interferon-gamma-based assays. Enferm Infecc Microbiol Clin. 2011;29:26\u201333.","journal-title":"Enferm Infecc Microbiol Clin"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0489-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15010-013-0489-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-013-0489-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T17:38:06Z","timestamp":1559497086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s15010-013-0489-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1007\/s15010-013-0489-9","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}